OpenURL Connection Search

Select item for more details and to access through your institution.

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Published in:
Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-01970-8
By:
- Levy, Antonin;
- Morel, Daphné;
- Texier, Matthieu;
- Sun, Roger;
- Durand-Labrunie, Jerome;
- Rodriguez-Ruiz, Maria E;
- Racadot, Severine;
- Supiot, Stéphane;
- Magné, Nicolas;
- Cyrille, Stacy;
- Louvel, Guillaume;
- Massard, Christophe;
- Verlingue, Loic;
- Bouquet, Fanny;
- Bustillos, Alberto;
- Bouarroudj, Lisa;
- Quevrin, Clément;
- Clémenson, Céline;
- Mondini, Michele;
- Meziani, Lydia
Publication type:
Article
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
Published in:
2021
By:
- Cabel, Luc;
- Berger, Frédérique;
- Cottu, Paul;
- Loirat, Delphine;
- Rampanou, Aurore;
- Brain, Etienne;
- Cyrille, Stacy;
- Bourgeois, Hugues;
- Kiavue, Nicolas;
- Deluche, Elise;
- Ladoire, Sylvain;
- Campone, Mario;
- Pierga, Jean-Yves;
- Bidard, Francois-Clement
Publication type:
journal article
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.
Published in:
NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00445-1
By:
- de Traux de Wardin, Henry;
- Dermawan, Josephine K.;
- Merlin, Marie-Sophie;
- Wexler, Leonard H.;
- Orbach, Daniel;
- Vanoli, Fabio;
- Schleiermacher, Gudrun;
- Geoerger, Birgit;
- Ballet, Stelly;
- Guillemot, Delphine;
- Frouin, Eléonore;
- Cyrille, Stacy;
- Delattre, Olivier;
- Pierron, Gaelle;
- Antonescu, Cristina R.
Publication type:
Article

Found: 3

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.

Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.